Toggle light / dark theme

Google links new LostKeys data theft malware to Russian cyberspies

Since the start of the year, the Russian state-backed ColdRiver hacking group has been using new LostKeys malware to steal files in espionage attacks targeting Western governments, journalists, think tanks, and non-governmental organizations.

In December, the United Kingdom and Five Eyes allies linked ColdRiver to Russia’s Federal Security Service (FSB), the country’s counterintelligence and internal security service.

Google Threat Intelligence Group (GTIG) first observed LostKeys being “deployed in highly selective cases” in January as part of ClickFix social engineering attacks, where the threat actors trick targets into running malicious PowerShell scripts.

New Investment Scams Use Facebook Ads, RDGA Domains, and IP Checks to Filter Victims

Cybersecurity researchers have lifted the lid on two threat actors that orchestrate investment scams through spoofed celebrity endorsements and conceal their activity through traffic distribution systems (TDSes).

The activity clusters have been codenamed Reckless Rabbit and Ruthless Rabbit by DNS threat intelligence firm Infoblox.

The attacks have been observed to lure victims with bogus platforms, including cryptocurrency exchanges, which are then advertised on social media platforms. An important aspect of these scams is the use of web forms to collect user data.

Human Verification

Four children have gained life-changing improvements in sight following treatment with a pioneering new genetic medicine through Moorfields Eye Hospital and UCL Institute of Ophthalmology.

The work was funded by the NIHR Research Professorship, Meira GTx and Moorfields Eye Charity.

The 4 children were born with a severe impairment to their sight due to a rare genetic deficiency that affects the ‘AIPL1’ gene. The defect causes the retinal cells to malfunction and die. Children affected are only able to distinguish between light and darkness. They are legally certified as blind from birth.

The new treatment is designed to enable the retinal cells to work better and to survive longer. The procedure, developed by UCL scientists, consists of injecting healthy copies of the gene into the retina through keyhole surgery. These copies are contained inside a harmless virus, so they can penetrate the retinal cells and replace the defective gene.

The condition is very rare, and the first children identified were from overseas. To mitigate any potential safety issues, the first 4 children received this novel therapy in only one eye.

The eye gene therapy was delivered via keyhole surgery at Great Ormond Street Hospital. The children were assessed in the NIHR Moorfields Clinical Research Facility, and the NIHR Moorfields Biomedical Research Centre provided infrastructure support for the research.


Complete the security check before continuing. This step verifies that you are not a bot, which helps to protect your account and prevent spam.